I bought more. Bit early at $0.51. Just don't understand why people would sell ahead of these results. We are ironically stuck around the buy-in level from the second capital raising in 2019. Unless its a 2020 buyer, it seems nuts to sell here ahead of CelGro results that are due any day and we know are very likely to be positive and basically allow OCC to perhaps improve on a 510K FDA approval for CelGro Nerve that is already in the bag from the animal nerve trials completion as was required by the FDA. I scratch my head with this one, but we are in markets where currencies move 30% on an emoji tweet!!
Further CelGro® nerve clinical trial data from all patients at 12 months, page-80
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
0.115(20.9%) |
Mkt cap ! $139.3M | |||
| Open | High | Low | Value | Volume |
| 56.5¢ | 68.0¢ | 56.5¢ | $2.002M | 3.169M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9999 | 66.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| OCC (ASX) Chart |